Currently, due to small differences in regulatory requirements, it is often impossible to transfer stock from one EU country to another to meet unexpected demand due to small differences in regulatory requirements. The regulatory efficiency and harmonization measures in the EU Pharmaceutical Strategy should be fast tracked to improve supply flexibility. Allowances for multi-lingual packaging or e-leaflets and streamlining regulatory systems through digitalization would further optimize supply and reduce the risk of medicine shortages. Policymakers could also incentivize investment in manufacturing diversification and greener technologies by advancing the Medicines Security Act
proposed by Medicines for Europe. As policymakers consider these and other measures to mitigate shortages, it's essential to maintain an open dialogue with the generics industry and Member States to determine the best course of action and avoid unintended consequences.